AP Pharma Inc. (HRTX)

Number of records: 50
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
17-Oct-22 4:36 PM
View: 
Peraza Lisa
VP, Chief Accounting Officer
AP Pharma Inc. (HRTX) 13-Oct-22Option Exercise 2,485----13%
18.96K to 21.45K
17-Oct-22 4:38 PM
View: 
Quart Barry D
Chief Executive Officer
Director
AP Pharma Inc. (HRTX) 13-Oct-22Option Exercise 19,768----13%
147.24K to 167.0K
17-Oct-22 4:36 PM
View: 
Manhard Kimberly
EVP, Drug Development
Director
AP Pharma Inc. (HRTX) 13-Oct-22Option Exercise 5,814----40%
14.67K to 20.49K
17-Oct-22 4:37 PM
View: 
Poyhonen John
President & CCO
AP Pharma Inc. (HRTX) 13-Oct-22Payment of Exercise 2,012$3.76$7,565.12(5%)
41.06K to 39.04K
17-Oct-22 4:38 PM
View: 
Szekeres David Leslie
EVP, Chief Operating Officer
AP Pharma Inc. (HRTX) 13-Oct-22Payment of Exercise 2,012$3.76$7,565.12(9%)
22.71K to 20.69K
17-Oct-22 4:37 PM
View: 
Poyhonen John
President & CCO
AP Pharma Inc. (HRTX) 13-Oct-22Option Exercise 5,814----16%
35.24K to 41.06K
17-Oct-22 4:36 PM
View: 
Peraza Lisa
VP, Chief Accounting Officer
AP Pharma Inc. (HRTX) 13-Oct-22Payment of Exercise 861$3.76$3,237.36(4%)
21.45K to 20.59K
17-Oct-22 4:38 PM
View: 
Quart Barry D
Chief Executive Officer
Director
AP Pharma Inc. (HRTX) 13-Oct-22Payment of Exercise 5,219$3.76$19,623.40(3%)
167.0K to 161.79K
17-Oct-22 4:36 PM
View: 
Manhard Kimberly
EVP, Drug Development
Director
AP Pharma Inc. (HRTX) 13-Oct-22Payment of Exercise 2,012$3.76$7,565.12(10%)
20.49K to 18.48K
17-Oct-22 4:38 PM
View: 
Szekeres David Leslie
EVP, Chief Operating Officer
AP Pharma Inc. (HRTX) 13-Oct-22Option Exercise 5,814----34%
16.89K to 22.71K
15-Jul-22 4:55 PM
View: 
Peraza Lisa
VP, Chief Accounting Officer
AP Pharma Inc. (HRTX) 13-Jul-22Payment of Exercise 860$3.01$2,588.60(4%)
19.82K to 18.96K
15-Jul-22 4:55 PM
View: 
Manhard Kimberly
EVP, Drug Development
Director
AP Pharma Inc. (HRTX) 13-Jul-22Payment of Exercise 2,012$3.01$6,056.12(12%)
16.69K to 14.67K
15-Jul-22 4:58 PM
View: 
Szekeres David Leslie
EVP, Chief Operating Officer
AP Pharma Inc. (HRTX) 13-Jul-22Option Exercise 5,814----44%
13.09K to 18.9K
15-Jul-22 4:55 PM
View: 
Peraza Lisa
VP, Chief Accounting Officer
AP Pharma Inc. (HRTX) 13-Jul-22Option Exercise 2,485----14%
17.34K to 19.82K
15-Jul-22 4:57 PM
View: 
Quart Barry D
Chief Executive Officer
Director
AP Pharma Inc. (HRTX) 13-Jul-22Option Exercise 19,768----15%
132.69K to 152.46K
15-Jul-22 4:55 PM
View: 
Manhard Kimberly
EVP, Drug Development
Director
AP Pharma Inc. (HRTX) 13-Jul-22Option Exercise 5,814----53%
10.87K to 16.69K
15-Jul-22 4:58 PM
View: 
Szekeres David Leslie
EVP, Chief Operating Officer
AP Pharma Inc. (HRTX) 13-Jul-22Payment of Exercise 2,012$3.01$6,056.12(11%)
18.9K to 16.89K
15-Jul-22 4:56 PM
View: 
Poyhonen John
President & CCO
AP Pharma Inc. (HRTX) 13-Jul-22Payment of Exercise 2,012$3.01$6,056.12(5%)
37.25K to 35.24K
15-Jul-22 4:57 PM
View: 
Quart Barry D
Chief Executive Officer
Director
AP Pharma Inc. (HRTX) 13-Jul-22Payment of Exercise 5,219$3.01$15,709.20(3%)
152.46K to 147.24K
15-Jul-22 4:56 PM
View: 
Poyhonen John
President & CCO
AP Pharma Inc. (HRTX) 13-Jul-22Option Exercise 5,814----18%
31.44K to 37.25K
04-May-22 7:01 PM
View: 
Manhard Kimberly
EVP, Drug Development
Director
AP Pharma Inc. (HRTX) 03-May-22Sale (Planned) 1,504$4.76$7,153.63(12%)
12.38K to 10.87K
15-Jul-22 4:57 PM
View: 
Quart Barry D
Chief Executive Officer
Director
AP Pharma Inc. (HRTX) 29-Apr-22Acquisition (other) 1,504$3.84$5,778.371%
131.18K to 132.69K
04-May-22 7:01 PM
View: 
Manhard Kimberly
EVP, Drug Development
Director
AP Pharma Inc. (HRTX) 29-Apr-22Acquisition (other) 1,504$3.84$5,778.3714%
10.87K to 12.38K
15-Jul-22 4:58 PM
View: 
Szekeres David Leslie
EVP, Chief Operating Officer
AP Pharma Inc. (HRTX) 29-Apr-22Acquisition (other) 1,505$3.84$5,782.2113%
11.59K to 13.09K
15-Apr-22 5:06 PM
View: 
Szekeres David Leslie
EVP, Chief Operating Officer
AP Pharma Inc. (HRTX) 13-Apr-22Option Exercise 5,814----75%
7.78K to 13.6K
15-Apr-22 5:04 PM
View: 
Poyhonen John
President & CCO
AP Pharma Inc. (HRTX) 13-Apr-22Payment of Exercise 2,012$6.07$12,212.80(6%)
33.45K to 31.44K
15-Apr-22 5:04 PM
View: 
Poyhonen John
President & CCO
AP Pharma Inc. (HRTX) 13-Apr-22Option Exercise 5,814----21%
27.64K to 33.45K
15-Apr-22 5:05 PM
View: 
Quart Barry D
Chief Executive Officer
Director
AP Pharma Inc. (HRTX) 13-Apr-22Option Exercise 19,768----17%
116.64K to 136.4K
15-Apr-22 5:03 PM
View: 
Manhard Kimberly
EVP, Drug Development
Director
AP Pharma Inc. (HRTX) 13-Apr-22Payment of Exercise 2,012$6.07$12,212.80(16%)
12.88K to 10.87K
15-Apr-22 5:03 PM
View: 
Manhard Kimberly
EVP, Drug Development
Director
AP Pharma Inc. (HRTX) 13-Apr-22Option Exercise 5,814----82%
7.07K to 12.88K
15-Apr-22 5:06 PM
View: 
Szekeres David Leslie
EVP, Chief Operating Officer
AP Pharma Inc. (HRTX) 13-Apr-22Payment of Exercise 2,012$6.07$12,212.80(15%)
13.6K to 11.59K
15-Apr-22 5:03 PM
View: 
Peraza Lisa
VP, Chief Accounting Officer
AP Pharma Inc. (HRTX) 13-Apr-22Option Exercise 2,484----16%
15.72K to 18.2K
15-Apr-22 5:05 PM
View: 
Quart Barry D
Chief Executive Officer
Director
AP Pharma Inc. (HRTX) 13-Apr-22Payment of Exercise 5,219$6.07$31,679.30(4%)
136.4K to 131.18K
15-Apr-22 5:03 PM
View: 
Peraza Lisa
VP, Chief Accounting Officer
AP Pharma Inc. (HRTX) 13-Apr-22Payment of Exercise 860$6.07$5,220.20(5%)
18.2K to 17.34K
14-Jan-22 5:08 PM
View: 
Quart Barry D
Chief Executive Officer
Director
AP Pharma Inc. (HRTX) 13-Jan-22Option Exercise 19,768----19%
102.09K to 121.85K
14-Jan-22 5:05 PM
View: 
Manhard Kimberly
EVP, Drug Development
Director
AP Pharma Inc. (HRTX) 13-Jan-22Payment of Exercise 2,012$8.30$16,699.60(22%)
9.08K to 7.07K
14-Jan-22 5:05 PM
View: 
Manhard Kimberly
EVP, Drug Development
Director
AP Pharma Inc. (HRTX) 13-Jan-22Option Exercise 5,814----178%
3.27K to 9.08K
14-Jan-22 5:09 PM
View: 
Szekeres David Leslie
EVP, Chief Operating Officer
AP Pharma Inc. (HRTX) 13-Jan-22Payment of Exercise 2,012$8.30$16,699.60(21%)
9.79K to 7.78K
14-Jan-22 5:06 PM
View: 
Peraza Lisa
VP, Chief Accounting Officer
AP Pharma Inc. (HRTX) 13-Jan-22Option Exercise 2,485----18%
14.2K to 16.68K
14-Jan-22 5:08 PM
View: 
Quart Barry D
Chief Executive Officer
Director
AP Pharma Inc. (HRTX) 13-Jan-22Payment of Exercise 5,219$8.30$43,317.70(4%)
121.85K to 116.64K
14-Jan-22 5:06 PM
View: 
Peraza Lisa
VP, Chief Accounting Officer
AP Pharma Inc. (HRTX) 13-Jan-22Payment of Exercise 966$8.30$8,017.80(6%)
16.68K to 15.72K
14-Jan-22 5:09 PM
View: 
Szekeres David Leslie
EVP, Chief Operating Officer
AP Pharma Inc. (HRTX) 13-Jan-22Option Exercise 5,814----146%
3.98K to 9.79K
14-Jan-22 5:07 PM
View: 
Poyhonen John
President & CCO
AP Pharma Inc. (HRTX) 13-Jan-22Payment of Exercise 2,012$8.30$16,699.60(7%)
29.65K to 27.64K
14-Jan-22 5:07 PM
View: 
Poyhonen John
President & CCO
AP Pharma Inc. (HRTX) 13-Jan-22Option Exercise 5,814----24%
23.84K to 29.65K
23-Dec-21 6:56 PM
View: 
Dissanaike Sharmila
Director
AP Pharma Inc. (HRTX) 22-Dec-21Grant 10,452----167%
6.25K to 16.7K
23-Dec-21 6:58 PM
View: 
Rodriguez Susan
Director
AP Pharma Inc. (HRTX) 22-Dec-21Grant 10,452----167%
6.25K to 16.7K
23-Dec-21 6:57 PM
View: 
Johnson Craig A
Director
AP Pharma Inc. (HRTX) 22-Dec-21Grant 10,452----368%
2.84K to 13.29K
23-Dec-21 6:58 PM
View: 
Christian Waage
Director
AP Pharma Inc. (HRTX) 22-Dec-21Grant 10,452----327%
3.2K to 13.65K
23-Dec-21 6:55 PM
View: 
Davis Stephen
Director
AP Pharma Inc. (HRTX) 22-Dec-21Grant 10,452----348%
3.0K to 13.45K
23-Dec-21 6:57 PM
View: 
Johnson Craig A
Director
AP Pharma Inc. (HRTX) 21-Dec-21Sale (Planned) 250$9.73$2,431.93(8%)
3.09K to 2.84K